# Vir Biotechnology, Inc.: Form 8-K, filed Aug 1, 2024

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2024-08-01
- Accepted by EDGAR: Aug 1, 2024, 16:10 ET
- Period: 2024-07-29
- Accession: 0001628280-24-034143
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828024034143/vir-20240729.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828024034143/

## Items reported

- Item 2.02: Results of operations
- Item 2.05: Exit or disposal costs
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828024034143/vir-20240729.htm

Filed Aug 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-034143. Last ingested by Listed: Oct 28, 2026, 08:38 ET. No prices; not investment advice.